Answers are grounded in this paper and cite their sources.
Hemostatic therapy with rFVIIa reduced growth of the hematoma but did not improve survival or functional outcome after intracerebral hemorrhage. (ClinicalTrials.gov number, NCT00127283 [ClinicalTrials.gov].).
No takes yet. Share an insight, caveat, or question.
Mayer et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: